NAL norwood abbey limited

ADDITIONAL EPI-LASIK PATENT GRANTED IN USMedical technologies...

  1. 8,005 Posts.
    lightbulb Created with Sketch. 29
    ADDITIONAL EPI-LASIK PATENT GRANTED IN US
    Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the US Patent Office has
    granted an additional patent of the Norwood EyeCare patent portfolio, relating to Epi-LASIK refractive
    surgery. The Epi-LASIK procedure enables laser corrections to the eye without needing to make a
    cut through the eye. The removal of the need for a ‘stromal cut’ (through the eye) is seen as a major
    advance over the most commonly performed procedure known as LASIK.
    The patent is numbered US Patent No. 7,156,859 and titled “Device for Separating the Epithelium
    Layer from the Surface of the Cornea of an Eye”.
    Overall, the patent which has a substantial number of individual claims, covers the concept of a
    device designed to ‘collect’ or ‘capture’ the separated epithelium layer as it is separated from the
    cornea of the eye.
    The patent is related to a mechanical device to at least partially separate a portion of an epithelial
    material of a cornea from the cornea and comprising both a ‘means for separating at least partially
    said portion of said epithelial material from said cornea; and a rotating drum positioned relative to said
    separator so as to be able to receive said separated portion of said epithelial material from said
    means for separating’.
    In addition, the patent covers a device that separates at least partially and receives at least partially a
    portion of an epithelial material of a cornea from said cornea, the device comprising both a ‘means for
    separating at least partially said portion of said epithelial material from said cornea; and a movable
    surface that is movable relative to said means for separating and is positioned so as to be able to
    receive said separated portion of said epithelial material’.
    The inventors are Dr Ioannis Pallikaris and Dr Harilaos Ginis and the patent has been granted to FOS
    Holdings S.A.
    Norwood Abbey has an exclusive license over the technology.
    The Company is continuing discussions in relation to potential collaboration/partnering arrangements
    in respect of Norwood’s EyeCare technology.
    To find out more about the Norwood group, visit www.norwoodabbey.com and
    www.norwoodeyecare.com
    For further information please contact:
    Lula Liossi
    Corporate Communications Manager
    Norwood Abbey Ltd
    +61-3-9770-0063
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.